Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSGet Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 72,600 shares, a growth of 7.1% from the December 15th total of 67,800 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 45,600 shares, the days-to-cover ratio is presently 1.6 days.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and issued a $9.00 target price on shares of Alpha Tau Medical in a research note on Friday, November 22nd.

View Our Latest Stock Report on Alpha Tau Medical

Alpha Tau Medical Trading Up 0.3 %

Shares of DRTS opened at $3.91 on Tuesday. The firm has a market capitalization of $273.39 million, a PE ratio of -9.09 and a beta of 0.80. The stock’s 50 day moving average is $3.03 and its two-hundred day moving average is $2.51. Alpha Tau Medical has a twelve month low of $1.75 and a twelve month high of $4.08.

Alpha Tau Medical Company Profile

(Get Free Report)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.

See Also

Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.